INVO Fertility, Inc. Common Stock (IVF) Q4 2025 Earnings
IVF·Reported May 6, 2026·Before market open
INVO Fertility, Inc. Common Stock reported Q4 2025 revenue of $1.9M (+14.3% YoY). Diluted EPS came in at $-2.75 (+76.5% YoY).
Revenue
$1.9Mmet estimate
Consensus: $1.9MDiluted EPS
$-2.75met estimate
Consensus: $-2.75
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2025 Earnings FAQ
Common questions about INVO Fertility, Inc. Common Stock's Q4 2025 earnings report.
INVO Fertility, Inc. Common Stock (IVF) reported Q4 2025 earnings on May 6, 2026 before market open.
INVO Fertility, Inc. Common Stock reported revenue of $1.9M and diluted EPS of $-2.75 for Q4 2025.
Revenue beat the consensus estimate of $1.9M by -. EPS beat the consensus estimate of $-2.75 by $0.00.
Compared to the same quarter a year prior, revenue grew 14.3% from $1.7M a year earlier and diluted EPS grew 76.5% from $-11.71.